Indication

Nonsquamous non-small cell lung cancer

Nonsquamous non-small cell lung cancer is a broad clinicopathologic grouping of epithelial lung malignancies that excludes squamous cell carcinoma, primarily comprising adenocarcinoma, large cell carcinoma, and other rare non-small cell subtypes. Read more about Nonsquamous non-small cell lung cancer

52 drugs 39 manufacturers

Advertisement

Drugs that treat it

Common Nonsquamous non-small cell lung cancer therapies.

Showing 1–9 of 52 drugs

CARBOPLATIN

MALIGNANT NEOPLASM OF THE OVARY·+3
APP PHARMACEUTI

AVASTIN (bevacizumab)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY·METASTATIC COLORECTAL CANCER·+6
GENENTECH

CARBOPLATIN

MALIGNANT NEOPLASM OF THE OVARY·+3
SICOR PHARM.

CARBOPLATIN

MALIGNANT NEOPLASM OF THE OVARY·+3
HOSPIRA/AMERINE

CARBOPLATIN

MALIGNANT NEOPLASM OF THE OVARY·+3
APP PHARMACEUTI

CARBOPLATIN

PLATINUM COMPOUNDS·MALIGNANT NEOPLASM OF THE OVARY·+3
SUN PHARMA GLOB

CARBOPLATIN

MALIGNANT NEOPLASM OF THE OVARY·+3
Teva Parenteral Medicines
Filter & compare in the drug finder →Opens the drug finder with Nonsquamous non-small cell lung cancer preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Nonsquamous non-small cell lung cancer.

Nonsquamous non-small cell lung cancer is a broad clinicopathologic grouping of epithelial lung malignancies that excludes squamous cell carcinoma, primarily comprising adenocarcinoma, large cell carcinoma, and other rare non-small cell subtypes.

Arising within the respiratory system—predominantly from the peripheral lung parenchyma and alveolar epithelium—it is the most prevalent form of non-small cell lung cancer.

Pathophysiologically, it is characterized by uncontrolled cellular proliferation and invasiveness driven by genomic alterations, demonstrating a significantly higher frequency of actionable oncogenic driver alterations—such as mutations in EGFR or KRAS and fusions in ALK, ROS1, or RET—than squamous histology.

Patients commonly present with pulmonary symptoms such as persistent cough, dyspnea, and hemoptysis, or with manifestations of locoregional invasion and distant metastasis.

Personalize your experience

Follow Nonsquamous non-small cell lung cancer and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it